Good day, and welcome to the HealthEquity Third Quarter 2026 Earnings Call. All participants will be in listen-only mode. Please note this event is being recorded. I would now like to turn the conference over to Richard Putnam. Please go ahead.

Thank you, Dave. Hello, everyone. Thank you for joining us this afternoon. This is HealthEquity's third quarter fiscal year 2026 earnings conference call. My name is Richard Putnam. I do investor relations for HealthEquity.

Joining me today are Scott Cutler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; and James Lucania, Executive Vice President and CFO. Before I turn the call over to Scott for prepared remarks, we note that a press release announcing our third quarter financial results was issued after the market closed this afternoon. It included certain non-GAAP financial measures that we will reference here today. You can find a copy of today's press release, including reconciliation of these non-GAAP measures with comparable GAAP measures on our Investor Relations website, which is ir.healthequity.com. We also note that our comments and responses today reflect management's views as of today, December 3, 2025, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business which could affect our forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from statements made here today. We caution against placing undue reliance on these forward-looking statements. We also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock, as detailed in our latest annual report on Form 10-K and in subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events. With that out of the way, let's go to Scott.

Thank you, Richard. Happy holidays, and welcome, everyone. I'll start with the key metrics that reflect our continued strong fiscal 2026 results and the progress we're making on our strategy. Steve will then speak to the regulatory environment, and Jim will walk through our third quarter financials and our raised outlook for fiscal year 2026. The team again delivered strong year-over-year growth and margin expansion across our key metrics in Q3, including revenue up 7%, net income up 806% year over year, a result that Jim will explain in more detail in a moment. Adjusted EBITDA up 20% driven by gross margin of 71% and adjusted EBITDA margin of 40%. HSAs grew 6%. CDB accounts up 3%, driving total accounts up 5%, and HSA assets up 15%. Behind these numbers is a clear strategy. Helping our members better save, spend, and invest for health and strengthening the flywheel in each of those areas. We are operating against a real affordability challenge for American families and employers. Health care costs continue to rise faster than wages, and both households and enterprises are looking for more practical ways to budget for health care today while preparing for tomorrow. HSAs sit at the center of our solution to that challenge. They are a proven engine for consumer-directed health care and long-term health savings. On the Better Save side of the flywheel, we are helping more members build tax-advantaged health savings and making it easier for them to contribute. HealthEquity ended Q3 with more than 17 million total accounts, including more than 10 million HSAs. We grew net CDB accounts by over 200,000 year over year, and Team Purple opened approximately 175,000 new HSAs from sales in the quarter. The average HSA balances grew 8% year over year, contributing to the 15% increase in…

Thanks, Scott. Let me touch on the public policy environment and how HSAs are being talked about in Washington. First, as the nation's leading custodian of HSAs and one of the first companies to launch them after their enactment over twenty years ago, we are strong believers in HSAs and the role they play in empowering healthcare consumers, helping employers focus their healthcare investment, and supporting a broader health system that delivers more value through lower costs and better outcomes. We are encouraged that policymakers in Washington are considering options that make HSAs available to more Americans and to use them as a key mechanism for delivering government support to improve affordability. We support President Trump's proposal that aligns with our long-standing belief that every American should have an HSA. At the same time, our core business is not predicting public policy or legislative outcomes, which specific bills will or won't pass, how ACA subsidies may change, or which legislative mechanisms might carry them. Our mission is to save and improve lives by empowering healthcare consumers. We stand ready to assist policymakers who are considering ways to expand the ability of more Americans to benefit from HSAs. As we shared during our last earnings call, we were encouraged for the first time in roughly twenty years there was meaningful expansion of HSA eligibility this summer. We view that change as a sign of growing recognition that HSAs are a powerful tool to help Americans prepare for current and future health care needs. There is a real affordability challenge affecting many American families, employers, and the health care system overall. A recent third-party study with some of our largest employers, representing nearly 1,000,000 employees, showed that those employers with higher HSA adoption experienced significantly lower per employee health care costs than those with lower adoption in HSAs, while their employees save more on premiums and taxes while growing their HSA balances. That is what consumer empowerment looks like in practice. Our position is straightforward: expand access to HSAs and strengthen consumer control. Our focus has been and will continue to be on helping policymakers understand how HSAs work in the real world, why they are a practical consumer-focused tool, and how HealthEquity, as a leader in this space, can help more Americans use HSAs to better save, spend, and invest for health under a variety of policy scenarios. We are encouraged by the elevation of HSAs in the national healthcare discussion and view this as a very positive development. And whatever form future legislation takes, our job does not change. I'll pass over to Jim now to discuss our financials. Jim?

Thanks, Steve. I'll review our third quarter fiscal 2026 GAAP and non-GAAP financial results. As always, we provide a reconciliation of GAAP measures to non-GAAP measures in the press release. Third quarter revenue increased 7% year over year. Service revenue increased 1% year over year to $123.1 million. Custodial revenue grew 13% to $159.1 million in the third quarter. The annualized yield on HSA cash was 3.53% for the quarter, as a result of higher placement rates and continued increase in balances and the number of accounts participating in enhanced rates. Interchange revenue grew 6% to $42.8 million, again, ahead of our 5% total account growth. Gross profit of $228.1 million resulted in a 71% gross margin in the third quarter, up from 66% in the third quarter last year. Service costs declined $10 million year over year in the quarter, even more than the $8 million in elevated service costs that impacted the third quarter last year. The third quarter of this year included approximately $300,000 of fraud reimbursements to members. And as Scott mentioned, we are ahead of our goal to achieve a run rate of one basis point of total assets in fraud costs per year. Our investments in fraud prevention and detection capabilities, AI service technologies, and our member-first secure mobile experience are delivering greater member functionality and satisfaction while improving margins at the same time. The actions we're taking are expected to drive efficiency in our operations not only this year but into fiscal '27 and beyond. Net income for the third quarter was $51.7 million or $0.59 per share. As Scott mentioned earlier, net income is up 806% compared to the third quarter last year, which included a $30 million one-time legal settlement. The settlement was backed out of last year's non-GAAP measures, so…

We will now begin the question and answer session. If at any time your question has been addressed and you would like to withdraw your question, please press star and then two. Our first question comes from Stan Berenshteyn with Wells Fargo. Please go ahead.

Yes. Hi. Thanks for taking my questions. On the direct HSA enrollment platform that you set up for qualified ACA members, what are your marketing plans there? And how should we think about the progression of your marketing expenses over the coming quarters pertaining to that? And maybe just a quick follow-up. Regarding your forward contracts, do you plan to derisk any longer duration assets beyond August 2027? Thank you.

Great, Stan. Thank you. I'll take the first two, and I'll let Jim talk about the forward contract strategy. So first, as it relates to the direct HSA enrollment, we call it the new retail enrollment flow. Obviously, to take advantage of the expansion provided by legislative activity over the summer. As we look at how we're going to compete for those new eligible HSA accounts, we want to make sure that number one, the enrollment experience is seamless, frictionless, and easy. And so we rolled out a new experience to make sure that we make it as easy and frictionless as it can be. So we're really pleased with that new experience flow. We also know that the new experience flow will roll into the core business as we go into the open enrollment season here. We believe that we've got the most competitive offer in the industry with a $25 match for a new account, and so that's one of the marketing features we're using. Going to market with integrated plan partners, and so we think with the power of our distribution platform that going to market with integrated plan partners helps to enhance the value proposition. And then last, as we look at the marketing expenditures, we've been leaning in on brand marketing, sort of upper funnel awareness and consideration as well as what I would call growth initiatives from paid search to key terms as well as the appearance of an education of HSAs in social channels to be able to drive awareness around this new opportunity. As we look at the opportunity overall, consistent with what we've talked about, we believe that this is a marathon, not a sprint. We think that these new enrollees are going to come in over time. We look to our plan partners, they're still early in terms of having integrated marketing plans and integrated technology to be able to bring in these new enrollees. And so we're taking a longer-term look at it. I'd say the early results on some aspects are encouraging. When I look at contribution levels as one example, the average contribution level of these new retail enrollees is about $1,550 versus industry-wide, your average contribution to an HSA would be about $1,800. So I think we're pleased with the quality of the retail members that are signing up. And again, we're going to be continuing to work with our plan partners to expand that. As it relates to the progression of the expenses, again, as we've looked at how to make sure we're going after that efficiency, as we had communicated before, in terms of quarterizing the sales and marketing expenditures, we're ramping that spend here in the fourth quarter to be able to go after coincident with open enrollment. Continue to lean into our brand and marketing activities and go-to-market rhythms to attract these new members. Maybe, Jim, you can talk about the forward contract strategy.

Yeah. Yeah. Sure. So, obviously, as you can see, we reached out a little bit further into the future here. In the previous quarter, we talked about we had hedged maturities out the furthest out was January '27. Obviously, during the last quarter, we stretched a bit into the summer of '27, and those deposits were like, we have a little mid-year bolus because of further migrations that came over. So there are some basic rates maturities in the middle of fiscal '28 for us. And then, yeah, I think you can sort of expect we'll reach out into the future a little bit to chip away. But as you can see, the updated maturity schedule, like, it's materially less that's maturing in fiscal '28 and fiscal '29. So the heavy concentration of what we've done had been on the front end.

Appreciate the color. Thank you.

And the next question comes from Alan Lutz with Bank of America. Please go ahead.

Good afternoon, and thanks for taking the questions. I want to follow-up to Stan's question around the bronze Exchange plans. Scott, you talked a little bit about going to market with integrated plan partners. Can you talk about the split between how much contribution you would expect from those plan partners? And would there be a material contribution from sort of standalone HealthEquity going direct, or is the vast majority or all of the growth going to come from HealthEquity with those integrated plan partners? Thanks.

Yeah. Thanks, Alan. You know, when we look at the core business, as you know, we have a very efficient distribution channel, and we receive the majority of our business through a partner, and that could be through an integrated plan partner or a relationship that we might have with brokers. And so we're going to continue to leverage that distribution channel. I wouldn't say I know exactly what that's going to look like for the retail channel because, again, many of these are coming individually to the market one-to-one and not coming with an associated file with an employer as an example, which is what the core new member acquisition looks like on our platform. And so that's why we've made such a significant investment in the retail experience to make sure that we're actually going to market with an attractive marketing message that we're educating the market around eligibility of bronze participants. I don't know if all Bronze participants know that the new enables them to have access to an HSA. And so there's awareness around what the product is, their eligibility, that would again as we're focused on our market activities, we're focused on targeting those places and those regions where we believe is the largest concentration of those potential members. And so again, I think as we look at it, we want to make sure that A) that we have a really strong integrated offering, and when I say integrated, it might be an offer that's got a click-through screen in that plan partners as well as our own and links directly to a sign-up on our own retail flow, as well as showing up as a retail offering out to a general member. And so again, as we think about how that's going to progress, that's another reason why we think this is going to be a market that yes, it's expanded, but it's going to grow over time as both awareness and consideration and then enrollment evolve for, again, what I would call a retail member.

Really helpful. And then for my follow-up, either for Scott or for Jim, the average cash per account has been pretty consistent around $1,700 per account. As you think about all the inflation we've seen over the past ten years or so, it seems like the minimum threshold before investing hasn't really changed much. Either for HealthEquity or at the industry level. We think about all the inflation that's gone through the market over that time period, is there an opportunity to increase that minimum threshold before HSA consumers can invest? Is that something where the market's moving? There an opportunity? Is that something you think about? Any color would be helpful. Thank you.

Yeah. So if I understand you correctly, the minimum threshold typically is set by our enterprise client. We want to make sure that people are taking advantage of the save, spend, and invest aspect of the product of the HSA. I think as we look at and take a step back and look at the industry overall, we still have a small percentage of members that are contributing at the max that they could allow. And so there's a big opportunity to effectively drive engagement in the actual HSA product as an example. And then if you look across the industry, only about 9% of HSA account holders are invested, and that's irrespective of what a minimum threshold would be. That number hasn't moved significantly over the years. And so on both of those things, we have strategies to drive how we can effectively try and move that. Number one, we really need to be able to educate the market as the market leader around what are the advantages of having these accounts. I think given the healthcare affordability crisis that all are experiencing today, I think that value proposition is very strong. In our conversations with our clients, given that the affordability is also hitting the enterprise, and that the enterprise can save on their annual increases in health care cost by driving greater adoption, we think we can have great partnership with our clients in driving that education awareness of one, sign up for a high deductible health plan and number two, contribute so that you have put more power and ownership over your dollar. The other thing is we think about bringing people along that progression of the flywheel from save to spend, which I'm sure we'll talk about later, to invest, we recognize that an investment actually contributes significantly more than a non-investor. And so we're actually looking at our own experience flow in the app to make sure that the setup for investing is easy, is seamless, that you know how to do this. That the investment choices and the lineup is attractive. Because we know a lot of people if they could be made aware at the time of setting up an account that also to think about how that account can be used can really drive that outcome over time. So I guess, Alan, I would just say it's on us to be able to drive those numbers. I think for the industry overall, raising awareness of the product, but also driving enrollment engagement what we think is through a great digital experience is the way that we can, you know, bend that curve over time.

Thanks, Alan.

And the next question comes from George Hill with Deutsche Bank. Please go ahead.

Yeah. I have two quick one quick one and one not so quick one. So I guess, number one, on the last earnings call, you guys had talked about seeing a slowdown in HSA market at a high level. I guess, number one, could you kinda provide some more like, an updated version of what you're seeing? And I'd be interested if you could comment on your conversations with employer sponsors around like, is the will they we're seeing a shift like, an acceleration benefit buy down from the commercial space are you seeing any greater shift towards HSAs in 2026? Versus 2025, kinda like the greater rate? And then my second question is kinda like a Scott, it's like, given some of the macro news that we've seen, there would seem to be other large custodial opportunities that have the potential to present themselves going forward as new markets develop? Is that anything that you guys would look at or And I'm kinda talking about, like, the Dell stuff and what we see more stuff that looks like the Dell stuff. Thank you.

The what the what stuff? Sorry?

The Dell stuff. You're talking about more make dollars on 25,000,000 children's accounts. Like, is that like, are there gonna be more of these opportunities to kinda create new markets for you guys? And how are you thinking about that?

Okay. And on your first part of your question, because you had a two-part on the first part, you said something about seeing something but you broke up. Just wanted to make sure. I've got your employer sponsors. Wait.

Yeah. Are you seeing in the oh, this is still my question. Are you seeing employer sponsors move people towards HSAs at an accelerating rate for 2026 given that we're seeing because utilization is so high, we're seeing benefit buy down at a higher rate than we've seen kind of in the last decade. Is that driving an acceleration of moving beneficiaries HSAs and just kind of what are you seeing in the commercial market?

Okay. Yeah. So I think I've got it. So on the commercial side or we call the client side, right now, what we're really driving towards is just the realization across the entire industry that health care costs are rising significantly for the enterprise as well as the consumer. Those health care costs are rising significantly more and multiples faster than wages are. And so as any enterprise and this is a CEO and a CFO level, conversation, when you look at those health care costs, which is one of the most significant input costs for your organization, you have to start to think about what are the strategies that we can address that. And so when we're talking affordability with our clients, we've been going with our analyzer product which actually helps an enterprise to be able to compare, for example, their enrollment rates, their contribution levels, what percentage of their employees are investors, what are the balances that they hold, and compare those to their industry average as well as what best in class would look like. What best in class looks like for our large enterprise clients are clients that are driving high deductible adoption or only providing that as an adoption, north of 75-80% and in fact, we've been working with the industry where we've done studies that have actually shown that employers that drive a strategy like that can save in the thousands of dollars per employee per year by driving that type of strategy. So the affordability strategy right now we think is resonating. In terms of it showing an accelerating rate, I think we're going to see that this year because we're having a lot of conversations with our clients around this and, you know, I think we're hoping that we will see greater adoption, this year over last year and so we'll see that in open enrollment which is happening right now. In terms of the macro news around Trump accounts or, you know, Michael Dell's contributions just the other day. I think, again, what we're seeing is that when you look at the triple tax advantage nature of an HSA account, and the massive needs that Americans have to handle their future healthcare needs as well as the fact that 40% of Americans can't even afford a $400 unexpected medical cost that the need for an HSA for all Americans is quite significant. And so this is actually why we're so active in Washington why this topic of health care affordability is on the desk of the president as well as senate and congress. In terms of driving solutions to address the affordability crisis. And we really do think that at HSAs, in terms of empowering healthcare consumption and preparing more Americans for their future healthcare needs is one of those solutions that's actually getting a lot of focus and attention in DC. I don't Steve, would you add anything more to that?

I think you're right on. I mean, we just as I mentioned in my comments, we just keep seeing the same thing overall. Over and over again when you see large populations of people going into HSAs. They spend less, and yet the people save more. I mean, obviously, you follow our custodial asset report pretty carefully, and you see how much money are in these assets. There's a lot of money. Not our money. We get a chance to manage it for a while. It's people's money. I just think that this concept of people having their own accounts, spending their own money, is working. And so the more we get that message out to employers, this study that was done just really has been done in the last month. We're gonna start spending more time with employers helping them understand that if they can take their adoption 30 or 40% adoption to 60 or 70%, then we're talking about thousands of dollars a year in savings per employee, which is pretty remarkable. Especially in this time where people are really struggling to pay health right now. So we're all in.

Thanks, George. That was comprehensive, guys. Thanks.

The next question comes from Mark Marcon with Baird. Please go ahead.

Good afternoon, and thanks for taking my questions. With regards to just the enhanced yield product, Jim, can you remind us where we are with regards to what percentage of the CAS assets are currently in the enhanced yield? And where do you anticipate that that would be by the time we get to January '27? And August '27. That's the first question. And then, Scott or Jim, the margin improvement continues to be really impressive. How much further can we continue to improve the efficiency and the in terms of the cost per account? How should we think about that because it has been quite impressive, but I'm wondering if you're if you think there's some pricing pressures that would come from employers that would, you know, slow down that rate of increase that we're seeing on the margins. Thank you.

Yep. Yeah. So as you know, we have not provided that number on a quarterly basis. So I'm not gonna say anything other than we started the year around $50.50. I would expect we'll give you an update when where we end the year. And as you know, like, there weren't a ton of maturities during '26. So our ability to move that number was not great. For the first three quarters of this year. And then obviously, we would expect a nice cash inflow in January that would with all the new accounts and employee employer matches, etcetera, that would help drive that number up a bit. The target we had set was to be at $60.40. By the end of next year. And, obviously, we're in very good shape to achieve that target. So I'd say stay tuned for our fourth quarter when we would give you that breakdown.

Mark, the only other thing I would add on the enhanced rate side, and then we've talked about this, when we look at the maturities that are rolling over into the enhanced rates, we do have about 90% plus adoption of enhanced rates as those things roll over. So as we look at this progression, it really is a business as usual in terms of what that progression is going to look like. We feel very strong about how that's going to naturally just evolve as those contracts mature. On margin improvement side, yeah, thanks for highlighting that. You know, we're really focused on making sure that the service that we provide is a great service, that we're continuing to improve that service and we truly do believe and know that, you know, for example, the use of more technology, more automation, we're in the early phases of deployment of AI across our service center. That we can do both things, both deliver a better experience and to be able to deliver it more efficiently. And so when I look at, for example, the early wins that we've had, in AI, whether that is in claims automation, how we're trying to get more people to engage in answers or in chat. And then now how we're rolling out more agentic experiences across our service center, we see significant opportunity for further efficiencies across how we serve our customers, but ultimately, are very much aligned to the idea that we can do it in a better way. And so take a typical phone interaction, if that's phone interaction, for example, is based on data it's a routine call, these could be things like checking a balance, replacing a card, trying to get into a password. These can be phone conversations today that might last five to ten minutes. That can be automated through an IVR to an agentic experience in less than a minute, resolve that issue, have that self-serve by a member, that's a better experience for the member and a much more efficient experience as well. And so again, strategically we look at the use of these technologies to drive that efficiency and we still believe that we're in the early innings of what that is ultimately going to look like across services as one example.

Great. Thank you.

Thanks, Mark.

And the next question comes from Brian Tanquilut with Jefferies. Hey, good afternoon, guys. Maybe as I think about as I think about the competitive nature of the HSA space, I mean, you guys have continually gained market share and maintained high client retention rates. So just curious, are you seeing any shift in pricing or competitive behavior, particularly as you expand to smaller employers and new exchange-based accounts and leveraging the scale and the product breadth to sustain that growth in margins in face of competition?

Yeah. Yeah. Thanks. So I'll take that. Yeah. It's a competitive market. We're pleased with our leading position in the marketplace. I think as we look at, the importance of the strategy and the flywheel of better save, spend, and invest, for health we truly believe that that's a differentiator in the strategy because it's not just about acquiring assets. It's really about how do we leverage the effective use of this savings vehicle for all three of those strategies. For example, on the spend side, you know, we have $40 billion that is spent in the industry today on programs and products and services that are HSA eligible. Increasingly more and more places where these products are being sold are advertising the use of use your HSA dollars to power up your purchasing power for this program or service. What we know and this is part of our strategy around marketplaces is that if we can provide greater, more seamless access to the spend part of the flywheel, we also know that that member is likely to contribute more. All this is also very much integrated into a four health value proposition which for us, since we're integrated with the most plan partners, and that's the entire focus of our platform, I think that drives greater differentiation for us in the marketplace. In terms of where we see the pressure, of course, are competitive processes. I think as we see the shift of our business go towards, HSA accounts, there's obviously a different revenue profile associated with that. Pricing pressure is typically seen at the high end of the market. And that's where there's a lot of competition more on the other types of accounts. But again, we feel very well positioned given the focus that we have on the platform being the leader in the space, to be able to drive a differentiated solution. I think when we look at our retention rates as one example of that in the high nineties percent, we're also really pleased that the quality of the service that we're providing to our clients also is showing up in the way we're able to retain clients in the business.

Awesome. Thank you.

And the next question comes from Sean Dodge with BMO Capital Markets. Please go ahead.

Yeah. Thanks. Maybe just going back to the AI and automation investments and coming at it from a little bit of a different angle. What percent of your cost structure can you address with these new capabilities or enhancements? Like high level, you're spending $320 million to $330 million a year on service cost. How much of that's labor? How much of that's like physical card cost? So what proportion of that can you go after? Then maybe conversely, like, what proportion is, like, technology and infrastructure spend that you really can't do much about? Or is that just not the right way of looking at it? Should we be thinking about these kinda long-term savings opportunities in a different way?

Yeah. Well, first, Sean, welcome back to the fold. We're excited to have you back. So yeah. So as you think about it, you know, AI has broad application across nearly all functions of our business. And so we're deploying agentic AI in, you know, again, across all of our functions. So if I break it down into a couple of areas to get to your question, so take on the services side, you know, we would kinda look at it as maybe a third, a third, a third between member services, client services, and then sort of like the back, back office type of operations. All three of those areas have slightly different needs and slightly different applications that AI can be deployed against. Most of our efforts today have really been focused on the member services portion of that. Because that's where a significant amount of call volume has when I think about that opportunity where we're starting from, and you should go back and look at the press release that we just put out in terms of our partnership with Parloa. We're looking at a lot of those voice interactions and trying to figure out how can we improve those interactions with an agentic experience. And so Parloa as an example will be our partner in terms of go-to-market there. On the client side, there's a lot of work that we do in terms of integrating files, taking large data sets in. A lot of that work we actually believe that we can automate with AI. So those are like a couple of things that, a, we have in market, we're thinking about, in addition to Claims AI as an example. When we look at product and technology slightly different, we certainly can see efficiencies that can be derived from AI in our product and tech team. But our product and tech team, we're really looking at AI to think about how is it that we can drive greater productivity. That productivity enhancements can show up in, you know, the speed and quality with which we can deploy code. But it also can be represented by the number of agents that we have deployed that are actually helping to create the next new product or the next new experience or the next new integration in a more seamless and integrated way. I think that's also where we have, you know, where we've really been focused on APIs and data to expose, again, those experiences that we can, you know, that we can roll out AI against. So, you know, as it relates to AI, we again we think we're in the early innings of a longer marathon. That we're optimistic because we're focused on it as a company and as each function to find those opportunities to, again, improve the experience, do it in a more efficient or a faster way.

Okay. That's great. Thanks again.

Thanks, Sean.

And the next question comes from Scott Schoenhaus with KeyBanc. Please go ahead.

Hey, guys. Thanks for taking my question. Wanted to follow-up on the app downloads. We're seeing close to 400,000 downloads in the month of October alone. We'll get the November reading here shortly. That's a big spike up, from what you've seen. Throughout the rest of the year. I'm wondering how that impacts your not only your new clients, but obviously your legacy clients on downloading the app, on loading the app? Pushing them towards enhanced rates. And then maybe to put a fine tune on the margin expansion since October was the last month of your quarter and you saw this big spike up. Can you attribute what that what those app downloads during open enrollment contributed to the margins or the person in the app versus a person not in the app, what that contributed to margins for the quarter, if so. Thanks.

Okay. Yeah. So first, as it relates to our app strategy, it starts with, you know, really our belief of creating a member-first secure mobile experience. You know, we've obviously made great strides this year on the security side. And I would say the security issues that we experienced early in the year was the first thing that said, hey. We really need to be able to provide a secure experience, and we know that we can do that best through the app. What we also know is that the app particularly for the younger generation of workers, remember that 75% of the workforce in the next five years will be millennial and Gen Z. I think their expectation of a digital experience is app-first or app-only. And so all of those things inform us to say driving towards app engagement is one of the most important things that we can do in the product experience itself. We've been rolling out passkey which effectively for the HealthEquity app any active members. So you wanna do anything in your app. You wanna sign in, log in, you wanna check your balance today. You have to download the app. And you have to authenticate via passkey. So that's driving the app adoption because it's required to authenticate through the platform itself. And so what I would expect is it will continue to drive app downloads. We're seeing really great success in terms of passkey and its success rate. Because in that experience as well, an app download via passkey, you don't have to remember your password anymore. Which again is a top call driver into our service center. So we do believe that with greater app adoption, with passkey adoption, one of our top call drivers goes away, which is I forgot my password. I wouldn't say that we have a, you know, a one-to-one relationship of app downloads to margin expansion. Although, again, in the example that I just provided, you know, we're eliminating those call drivers that certainly does contribute to a lower cost to serve for those members. So again, I think for us it's just a strategic priority but it also is gonna be a more efficient channel to serve members with either questions or engagement or education. So I think for us in looking at, you know, how many active users we have in the app, how many people are downloading it, is gonna be for us kind of a key indicator of, you know, how engaging the experience is for our member. And certainly most of the investment that we have or a lot of the investment that we have in product and tech that's incremental is going into making that app experience, that product experience truly remarkable.

Thanks, Scott.

The next question comes from Steven Valiquette with Mizuho Securities. Please go ahead.

Hi. Thanks. Yeah. Good afternoon. Thanks for taking my question. I guess I just want to follow-up on your positive comments about remaining optimistic on the new account growth in the fiscal fourth quarter. Kinda grounded on the work you're doing with employers. So I certainly get all the higher demand by employers that wanna reduce rising medical costs. But I guess given the last couple of quarters, you were talking about some of that macro uncertainty soft labor market. So I want to just isolate just on that part in particular. I guess the question is, are you still worried about the soft labor market there's just such strong demand to control medical costs as more than offsetting that? Or are you much less worried about the macro end markets and the impact from that versus what your view was, like, six months ago? Just trying to hone in on that part of the know, the overall outlook. Thanks.

Yeah. So our view on the macro hasn't changed. In fact, our story around the macro has been consistent over the course of the year. Where we see the macro showing up is effectively, you know, maybe less job growth or job churn for remember, only this cohort of members that bring in. You know, we've got over twenty years of cohorts of members. The least valuable cohort is the members that signing up this year. Typically, they're coming in new with zero balances. So it will have no impact on our near-term financials overall in terms of, you know, what Q4 looks like or quite frankly, even over the course of this, of the course of this year. So our view on the macro is unchanged and I think all of this you know, is of balanced because while the macro might be weak, the value proposition for enterprises is quite large given the affordability challenges with health care costs rising. Also have the benefit associated with the first expansion of the HSA market through we've talked with the Bronze plan and the retail expansion. And we're going to market in a new rhythm with a really strong value proposition. Again, it's tied to affordability, that's essentially going and educating, you know, our enterprise clients around here are the strategies that you can be using to drive adoption. So Steve I think it's all of those things you know, we see optimism in the quality of the enterprise pipeline that we see. kinda combined. But, again, as we look at our optimism coming into Q4, we're optimistic around the retention rates, with our clients that we've seen going into Q4. And Q4 is always the biggest quarter of the year always, you know, and effectively, we drive a strategy over the course of the entire year to make Q4 selling season as strong as it can be.

Okay. Thanks.

Thanks, Steve.

And the next question comes from Greg Peters with Raymond James. Please go ahead.

Hey, good afternoon, guys. Thanks for taking my question. Is there any update you could provide on what you're seeing in the M&A environment for additional HSA portfolios? And could you provide us an update on how you're thinking about capital allocation in fiscal twenty seven?

Yeah. So as we think about capital allocation, you know, unchanged. We have had a very strong cash-generating profile in the business. In fact, first nine months of the year exceeding what we did all of last year, you know, as we look at what we're going to do to deploy that, you know, we'll look at continuing stock buybacks, continue to pay back debt, and we'll look at M&A from an opportunistic perspective. And when we say opportunistic, we just really have a high bar in terms of what is gonna be an acquisition that would make sense. You know, certainly, portfolio acquisitions are quite attractive to us. Pretty much down the fairway, so we would look at those. And so, again, I would say all of that remains unchanged. And I think as we look at the earnings profile of the business and the cash generation profile of the business, and the strength of that, we're excited with what we can do with respect to shareholders with that cash in a disciplined and shareholder-friendly way.

Thanks for the color on that.

Thanks, Mitch.

And the next question comes from David Roman with Goldman Sachs. Please go ahead.

Thank you. Appreciate you're taking the question. Jim, I heard we heard the comments that you're going to give 27 guidance. At JPMorgan in January. But just one dynamic that sticks out here is the magnitude of HSAs expected to reprice in '27 versus both what's remaining here in '26 and also what will occur in '28 and '29. You maybe just give us some parameters how to think about that repricing that's coming and in comparison to the current yield that just sitting under 2%?

Yeah. Well, yeah, nothing's really changed with the story there. Right? They will reprice they will reprice higher. Obviously, we've hedged some of those for pricing. So you have with sort of much more certainty than you've had in prior years where they're going to reprice. But as for the sort of orderly outlook, it's not numbers that we've provided. So I can't sort of can't get into that. But, yeah, like, as Scott sort of said to the earlier question, there's no risk to the actual migration. Right? The basic rate to enhance rates, migration. We're up to, like, the thirtieth wave of contracts migrating. So it's I'm not gonna call it autopilot. It's work. There's notices that go out. Communications to all those affected members. But we, like Scott said, sort of 90-ish percent adopt in. So it's going to happen. Obviously, we do have large Q4 flows into our business. So that's always gonna be part of the math. So you gotta wait for the full year to get the actual impact of that. Where you have in the bag numbers for '27 is what we're gonna reprice here in Q4. And to get the full benefit of what's repricing in '27, that's really a '28 revenue uplift item. So I will tell you what our yield forecast is in a few weeks. At JPMorgan.

Okay. Look forward to that. And maybe just a follow-up. One of the earlier questions addressed the significant improvement you're seeing in cost to service members that obviously is coming through in the gross profit improving here year over year. Can you maybe just go into a little bit more detail, Scott, where you are redeploying some of that top line and gross profit upside back into the business? What are some of the key investment priorities for you both from a T&D perspective as well as headcount standpoint? And when how that starts to show up driving a return in the business either in fiscal twenty seven or thereafter?

Yeah. So, you know, a couple of things. You know, one, we're obviously showing, you know, some of that actually just dropping all the way through to the bottom line. So, you know, I would expect for us to continue to seek to do that. I think when it looks at, you know, our operating expenses as an example, I don't expect a significant change in the framework, for example, as to percentage of revenue that we allocate towards sales and marketing and product and technology. So we want those efficiencies, but we also see that opportunity as we're also growing on the top line to be able to reinvest back in the business. I think consistent with the earlier question that I highlighted below, that I highlighted before, on the service side, as it relates to gross margin. You know, that's where we're gonna continue to focus on the efficiency gains. And that's going to be through, you know, we highlighted some of the actions that we took earlier this year to drive those efficiencies. We've obviously had a tremendous amount of success on the efforts around reducing fraud. And even outside of that when you look at taking out the year-over-year benefit that we had from fraud savings but essentially just looking at how much more efficient that we can be on the service line with top line growth we're gonna continue to drive that through the deployment of AI and deployment of technology across that. When it gets down to our product and technology side, as I look at what are our big priorities going into the year, you know, I really think it starts with the app experience. How is it that we can create a product experience that is engaging for our members, to make…

Thanks, David. Thanks so much.

And the next question comes from Aleksey Gavalev with JPMorgan. Please go ahead.

Hi. Thanks for taking my question. This is Destiny on for Aleksey. You mentioned encouraging early adoption of the GLP-1 program. I just wanted to touch on what's the revenue sharing opportunity for HealthEquity, like, referring members to the agile platform and if this is a material revenue opportunity for the company. Thanks.

Yeah. So certainly right now, it's immaterial to our current results. And I would say that we're really pleased with the uptake effort. You know, I think as we look at why we think we're in a strong position, we have 10 million members. They're spending significantly across these on products and services. So bringing those experiences into the platform itself is something that we're excited about. You know, over time, this would show up in service revenue much like our marketing arrangements we have today with FSR HSA store show up there. You know, we think the model is going to evolve over time kind of a combination of the recurring administrative fee associated with members signing up to programs. You can look to other direct-to-consumer healthcare platforms in terms of what that looks like. As well as essentially the administration fees or fees that we could get by promoting product or providing affiliate links to other platforms. So again, I think that the model is going to evolve over time. Really driven by a tailwind of member adoption. Member adoption of these, again, programs, products, and services.

Thanks, Destiny.

And the next question comes from David Weissen with BTIG. Please go ahead.

Hi. Can you just size the TAM expansion with the brand product opportunity? I think there's, like, 7 million people enrolled in bronze. Compared to the 10 that you have in HSAs now. It sounds a very significant opportunity. Just any color on like, how to quantify this? Maybe I think, Steve, you may have quantified this in the past. Thanks.

Yeah. Sure. Thanks, David. Yeah. So 7 million is what's in it now. And you know, the question is what happens with these premiums going up and what's gonna happen with the subsidies? And, of course, you've all read all about that. We don't know the answer to that as we said earlier, but there is a possibility we're starting to see some people and some reports from our health plan saying that people are going from silver to bronze. Which is, you know, a good opportunity because people that are in silver go down to bronze, they're probably more likely to fund the account. Accounts. We started to set up some of these accounts. It's very early innings, but we're starting to see account contributions being stronger than we frankly thought. People are putting money in these accounts, which is exciting. So, look, whether all now and remember, it's 7 million people and so our estimate is that's probably closer to a couple two or 3 million households, if that makes sense. The question is, what percentage of those with migration from silver would the industry be able to capture? I know there's a CMS report out there that's been circulated that things they think there'll be 1.6 million people in these HSAs coming out of this open enrollment cycle that we're gonna we're doing everything we can to get more than our fair share of those. But it's really hard to know exactly what it's gonna be like. I can tell you though that it's gonna be one of these journeys, David, because the beautiful thing about the health savings account in helping people pay for their out of pocket, Scott mentioned that crisis people have. Most people accept those who have HSAs, obviously. Don't have the ability…

Can you use HSA dollars to pay the premium? So can you buy the premium, like, pay the in premium on a tax-advantaged basis?

Oh, there's only a couple situations where you can use HSA dollars to pay premium. One is if you're just unemployed. The other one is if you're formally on COBRA. But I'm talking about and other lawmakers they're saying why not roll money into HSAs change the law. It doesn't take a lot of change. Just to say you can use it for premiums more broadly speaking, and we're completely supportive of that. We are the technology is there. Obviously, our expertise would be that, yeah, the money comes in. To the HSA. They wanna use on premiums. Let them use it on premiums or let it use it let them use it on their out of pockets. Let them use it on our marketplace. You name it. So right now, you cannot unless you're unemployed. And on COBRA.

Thanks a lot.

Thanks, David.

This concludes our question and answer session. I would like to turn the conference back over to Scott Cutler for any closing remarks.

Thanks a lot. It's been a year since I was first introduced to everybody here on our last Q3 earnings call. I joined HealthEquity knowing the company by reputation only and I've just been so humbled and honored to be able to be side by side with our passionate Purple teammates. Over the last year. We really have a significant opportunity ahead of us. We're gonna be going after that aggressively. We think as we can reach and influence more employers, and more families turn to HSAs to address affordability, and take control of their health care spending that we're gonna be closer to achieving the mission that Steve set out for us to so ambitiously many, many years ago. So we welcome you, our shareholders, and everybody to help continue on this journey with us. So thank you today.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.